scholarly journals COVID ‐19 vaccine acceptability among people in Australia who inject drugs: Implications for vaccine rollout

2021 ◽  
Author(s):  
Paul M. Dietze ◽  
Cristal Hall ◽  
Olivia Price ◽  
Ashleigh C. Stewart ◽  
Sione Crawford ◽  
...  
2011 ◽  
Vol 26 (5) ◽  
pp. 751-760 ◽  
Author(s):  
J. E. Painter ◽  
L. M. Gargano ◽  
J. M. Sales ◽  
C. Morfaw ◽  
L. M. Jones ◽  
...  

Vaccine ◽  
2012 ◽  
Vol 30 (36) ◽  
pp. 5363-5367 ◽  
Author(s):  
Pieter Remes ◽  
Veronica Selestine ◽  
John Changalucha ◽  
David A. Ross ◽  
Daniel Wight ◽  
...  

2018 ◽  
Vol 31 (6) ◽  
pp. 583-591 ◽  
Author(s):  
Abraham Degarege ◽  
Karl Krupp ◽  
Kristopher Fennie ◽  
Vijaya Srinivas ◽  
Tan Li ◽  
...  

2013 ◽  
Vol 40 (1) ◽  
pp. 75.1-76 ◽  
Author(s):  
Sarah M Tiggelaar ◽  
Matthew Rafalski ◽  
Mario A Davidson ◽  
Yan Hu ◽  
Lonnie Burnett

2016 ◽  
Vol 6 ◽  
pp. 29-35
Author(s):  
Eve Dubé ◽  
Dominique Gagnon ◽  
Manale Ouakki ◽  
Sylvie Belley ◽  
Hélène Gagné ◽  
...  

2021 ◽  
Vol 8 ◽  
Author(s):  
Ze-Hao Ye ◽  
Zhao-Zhen Liu ◽  
Si-Tong Cui ◽  
Zhen-Xing Chu ◽  
Yong-Jun Jiang ◽  
...  

Background: Despite the insupportable burden caused by the human papillomavirus (HPV) and high vaccine acceptability, vaccination programs are not currently available for men who have sex with men (MSM). We aimed to assess HPV infection by examining the willingness for vaccination among MSM and cost-effectiveness of the Chinese 2-valent HPV vaccine.Methods: We recruited MSM in Shenyang, China between July and December 2020 to conduct anal HPV testing and an online survey regarding HPV-related knowledge and vaccine acceptability. We performed a cost-effectiveness analysis to evaluate the incremental cost-effectiveness ratios (ICERs) of the Chinese 2-valent HPV vaccine.Results: A total of 234 participants completed the online survey; of those, 203 were successfully tested for HPV. The median age was 30 years [interquartile range (IQR): 23–38 years]. Most participants had at least undergraduate education (136/234, 58.1%). The acceptability rate for the free HPV vaccine was 57.7% (135/234). The prevalence of HPV types 16 and 18 was 14.9% (18/121) and 26.8% (22/82) in the willing and unwilling to vaccinate groups, respectively (P > 0.05). The prevalence of high-risk HPV among participants aged <30 and ≥50 years was 48.6 and 38.9%, respectively. Using the Chinese per capita gross domestic product (GDP) as a threshold, the Chinese 2-valent HPV vaccine would be a “very cost-effective” strategy, with an ICER value of USD 4,411. This evidence showed that the Chinese 2-valent HPV vaccine was more cost-effective than other imported vaccines.Conclusions: Targeted strategies should be utilized in MSM with different rates of vaccine acceptability. A pilot HPV vaccination program based on the Chinese 2-valent HPV vaccine for MSM is urgently warranted to reduce the burden of HPV and anal cancer.


2021 ◽  
Author(s):  
Andrew Marvin Kanyike ◽  
Ronald Olum ◽  
Jonathan Kajjimu ◽  
Daniel Ojilong ◽  
Grabriel Madut Akech ◽  
...  

Abstract Background COVID-19 is still a major global threat and vaccination remains the long-lasting solution. Unanimous uptake of the COVID-19 vaccine is required to subsequently avert its spread. We therefore, assessed COVID-19 vaccine acceptability, hesitancy, and associated factors among medical students in Uganda. Methods This study employed an online descriptive cross-sectional survey among medical students across 10 medical schools in Uganda. A structured questionnaire as a Google form was sent to participants via WhatsApp. Data was extracted and analyzed using Microsoft Excel 2016 and STATA 16. Descriptive statistics, bivariate and multivariable analyses were performed. Results We surveyed 600 medical students, 377 (62.8%) were male. COVID-19 vaccine hesitancy and acceptability were 30.7% and 37.3%, respectively. Factors associated with vaccine acceptability were being female (aOR = 1.9, 95% CI: 1.3–2.9, p = 0.001), being single (aOR = 2.1, 95% CI 1.1–3.9, p = 0.022). Very high (aOR = 3.5, 95% CI 1.7–6.9, p < 0.001) or moderate (aOR = 2.2, 95% CI 1.2–4.1, p = 0.008) perceived risk of getting COVID-19 in the future, receiving any vaccine in the past 5 years (aOR = 1.6, 95% CI 1.1–2.5, p = 0.017), and COVID-19 vaccine hesitancy (aOR 0.6, 95% CI 0.4–0.9, p = 0.036). Conclusions This study revealed low levels of acceptance towards the COVID-19 vaccine among medical students, low self-perceived risks of COVID-19, and many had relied on social media that provided them with negative information. This poses an evident risk on the battle towards COVID-19 in the future especially when these future health professions are expected to be influencing decisions of the general public towards the same.


Sign in / Sign up

Export Citation Format

Share Document